Company Financials

Novartis Financials

Swiss franc

business Novartis Company Profile

Main Stock Listing

SIX: NOVN

Market Capitalization CHF212.17 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 18.96
Forward PE 15.26
Price to Sales TTM CHF3.76
Price to Book MRQ CHF5.99
Enterprise to Revenue 4.14
Enterprise to EBITDA 9.35

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 25.53%
Operating Margin 31.93%
Return on Assets TTM 12.13%
Return on Equity TTM 32.62%

Income Statement

Revenue TTM CHF44,743,582,824
Revenue per Share TTM CHF28.81
Quarterly Revenue Growth 9.00%
Gross Profit TTM CHF34,115,671,922
EBITDA CHF18,204,761,920
Net Income to Common TTM CHF11,424,011,909
Diluted EPS TTM CHF5.78
Quarterly Earnings Growth YoY 23.20%

Balance Sheet

Total Cash MRQ CHF7,673,684,756
Total Cash per Share MRQ CHF5.04
Total Debt MRQ CHF
Total Debt to Equity MRQ 71.55
Current Ratio MRQ 0.88
Book Value per Share MRQ CHF18.30

Cash Flow

Operating Cash Flow TTM CHF16,726,061,915
Levered Free Cash Flow TTM CHF12,706,762,587

NOVN Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 1,918,792,119
Float Shares 1,826,824,413
Avg 10 Volume 3,154,948
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 0.04%
% Held by Institutions 41.19%

Stock Price Summary

Beta 0.44
Fifty Two Week Low CHF81.10
Fifty Two Week High CHF110.88
Fifty Two Week Change 18.83%
Day 50 MA CHF104.90
Day 200 MA CHF98.65

Dividends and Splits

Forward Annual Dividend Rate CHF14.00
Forward Annual Dividend Yield 12.77%
Trailing Annual Dividend Rate CHF3.50
Trailing Annual Dividend Yield 3.19%
Payout Ratio 54.35%
Dividend Date 2025-03-13
Ex Dividend Date 2025-03-11
Last Split Factor
Last Split Date 2023-10-04